{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ03947",
      "entity_text" : "FITC-LPS",
      "entity_type" : "protein"
    },
    "participant_a" : [ {
      "in_model" : true,
      "identifier" : "uaz:UAZ03947",
      "entity_text" : "FITC-LPS",
      "entity_type" : "protein"
    }, {
      "in_model" : true,
      "identifier" : "uaz:UAZ03956",
      "entity_text" : "hCAS",
      "entity_type" : "protein"
    } ],
    "hypothesis_information" : false
  },
  "verbose_text" : "Independently of the concentration used, TW2 (CMC; 0.0074% w/v) was able to inhibit the binding of FITC-LPS to hCAS, while, as expected, concentrations of about 0.0125% (above the CMC) were required to completely inhibit the binding of FITC-LPS to empty wells (XREF_FIG).",
  "reading_complete" : "2020-08-08T14:59:13Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T14:51:15Z",
  "trigger" : "inhibit",
  "evidence" : [ "FITC-LPS to hCAS, while, as expected, concentrations of about 0.0125% (above the CMC) were required to completely inhibit the binding of FITC-LPS" ],
  "pmc_id" : "4889133",
  "score" : 0
}